The long noncoding RNA DLGAP1‐AS2 facilitates the malignant progression of cholangiocarcinoma via miR‐505 and GALNT10 and may have potential as a novel target for cholangiocarcinoma therapy. The gene discussed is DLGAP1; the disease is cholangiocarcinoma.